Visit | The proportion of positive malaria tests by intervention groupa | Comparison between control and intervention groupsb,c | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Control vs. CSB | Control vs. Milk-LNS | Control vs. Soy-LNS | |||||||||
Control | CSB | Milk-LNS | Soy-LNS | Global P-value | PR (95% CI) | P-value | PR (95% CI) | P-value | PR (95% CI) | P-value | |
All ages combined | 12.1 % (63/519) | 17.2 % (90/522) | 12.2 % (66/541) | 14.0 % (73/520) | 0.023 | 1.72 (1.19, 2.49) | 0.004 | 1.19 (0.81, 1.74) | 0.372 | 1.32 (0.88, 1.96) | 0.177 |
9 months | 6.8 % (10/146) | 12.4 % (17/137) | 8.1 % (12/149) | 7.5 % (10/134) | 0.088 | 2.63 (1.20 to 5.75) | 0.015 | 1.60 (0.68 to 3.76) | 0.286 | 1.66 (0.68 to 4.06) | 0.267 |
12 months | 8.5 % (11/129) | 15.5 % (20/129) | 10.1 % (14/139) | 10.9 % (14/128) | 0.329 | 1.86 (0.92 to 3.76) | 0.083 | 1.29 (0.59 to 2.82) | 0.531 | 1.33 (0.62 to 2.90) | 0.465 |
15 months | 8.7 % (9/104) | 18.5 % (22/119) | 8.3 % (9/108) | 15.6 % (19/122) | 0.015 | 3.24 (1.46 to 7.17) | 0.004 | 1.50 (0.57 to 3.90) | 0.411 | 2.53 (1.13 to 5.66) | 0.024 |
18 months | 23.6 % (33/140) | 22.6 % (31/137) | 21.4 % (31/145) | 22.1 % (30/136) | 0.957 | 1.02 (0.64 to 1.61) | 0.936 | 1.00 (0.63 to 1.60) | 0.988 | 0.90 (0.56 to 1.45) | 0.671 |